WO1997041254A1 - Improved probing of specific nucleic acids - Google Patents

Improved probing of specific nucleic acids Download PDF

Info

Publication number
WO1997041254A1
WO1997041254A1 PCT/SE1997/000737 SE9700737W WO9741254A1 WO 1997041254 A1 WO1997041254 A1 WO 1997041254A1 SE 9700737 W SE9700737 W SE 9700737W WO 9741254 A1 WO9741254 A1 WO 9741254A1
Authority
WO
WIPO (PCT)
Prior art keywords
probe
target
sequence
detectable
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SE1997/000737
Other languages
English (en)
French (fr)
Inventor
Ulf Landegren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP97921072A priority Critical patent/EP0951565B1/en
Priority to DE69719557T priority patent/DE69719557T2/de
Priority to CA002252817A priority patent/CA2252817C/en
Priority to JP9538820A priority patent/JP2000508920A/ja
Priority to AT97921072T priority patent/ATE233826T1/de
Publication of WO1997041254A1 publication Critical patent/WO1997041254A1/en
Anticipated expiration legal-status Critical
Priority to US10/029,913 priority patent/US7351528B2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6823Release of bound markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase

Definitions

  • the present invention relates to improved methods for probing of specific nucleic acids. More specifically, the invention relates to a method of detecting specific nucleic acid sequences as well as probes and detecting kits therefor.
  • Detection of unique target sequences in the complexity of the human genome requires highly specific detection reagents. This form of gene detection permits target sequence variants to be screened for and it represents one of the most important modalities of gene analysis.
  • the hybridization of single oligonucleotides in general does not afford the requisit specificity, while the combination of two probes such as in PCR (polymerase chain reaction) or
  • OLA oligonucleotide ligation assay
  • WO 95/22623 discloses a probe designed to be circularized in the presence of a target sequence and caused to close around the target-containing nucleic acid strand such that the cyclic probe will interlock with and thereby be efficiently linked to the target nucleic acid to be detected. Because of the helical nature of double-stranded nucleic acids, such as DNA, circularized probes will be wound around the target strand, topologically connecting probes to target molecules through catenation, in a manner similar to a padlock. Such covalent catenation of probe molecules to target sequences results in the formation of a hybrid that resists extreme washing conditions, serving to reduce non-specific signals in genetic assays.
  • any probes hybridizing in a non-specific manner may therefore be removed by subjecting the target to non-hybridizing conditions and/or exonuclease activity.
  • the circular probe is properly detectable, such as by being suitably labelled, it may then be detected to indicate the presence of the target molecule.
  • the present invention relates to improved methods of detecting specific nucleic acid sequences by means of circularizable probes as well as detecting kits and probes therefor giving considerable advantages in specificity, noise reduction and kinetics compared to prior art.
  • the circularizable probes are designed such that they report the presence of a target sequence by allowing a detectable moiety to remain bound if and only if the probe has been cyclized in a target-dependent linking reaction.
  • the invention provides a method of detecting a target nucleic acid sequence in a sample by contacting the sample with a detectable probe to hybridize the probe to the target sequence, and detecting the hybridized probe, said probe (below called padlock probe) having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence.
  • the method comprises the following steps: a) hybridizing the probe ends to the target sequence under hybridizing conditions; b) covalently connecting the ends of the hybridized probe with each other to form a circularized structure; c) washing under denaturating conditions.
  • the method is characterized in that one end part of the probe is provided with a cleavable or dissociable detectable function, and the method comprises the further steps of: d) cleaving or dissociating said detectable function; e) separating probes with connected ends from probes with non-connected ends by washing under denaturing conditions; and f) detecting the presence and, if desired, location of the remaining probe as indicative of the presence of the target nucleic acid sequence.
  • the detectable function can be cleavable by being connected to the remainder of the probe via a cleavable site or linker located on the same probe end as the detectable function.
  • a dissociable detectable function can be provided on a second padlock probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the first probe sequence.
  • Such a second padlock probe can be added to the probe either before or after the probe has been reacted with the target sequence. It is also possible to provide the dissociable detectable function on the target-sequence specific probe if the second padlock probe is immobilized to a support.
  • the padlock probe has two linear probe ends.
  • One of the probe ends contains a detectable function which is capable of being either cleaved off or dissociated from the probe end.
  • At least one of the probe ends of the padlock probe is branched, e.g. with up to ten branches or even more, and a cleavable or dissociable detectable function is provided on each of the branches or arms.
  • the branch ends may be specific for the respective sequence variants to be distinguished in the assay, for instance to identify allelic sequence variants or to perform a quantitative comparison between similar sequences.
  • the covalent linking or connecting between two ends of a probe anchor a detectable signal. If no linking has ocurred, the signal will not be detected. Examples of preferred signals are fluorophores, radioisotopes, haptens, enzymes etc.
  • the covalent connection of the probe ends to each other after hybridization to the target sequence may be performed by enzymatic, ribozyme-mediated or chemical ligation, preferably enzymatic ligation.
  • the probe may be designed to hybridize to the target molecule such that an interspace is left between the probe ends, and that at least one additional probe is provided which is designed to hybridize to the target molecule in this interspace, whereupon the hybridized probes are covalently interconnected.
  • the probe or probes are designed to hybridize to the target molecule to leave a small gap between adjacent probe ends. This gap or gaps are then filled by an extension reaction prior to covalently interconnecting the probe ends.
  • the method of the invention may particularly be used for detecting, quantifying and distinguishing between sequence variants with regard to one or several target sequences in a sample.
  • Examples of applications include distinction between normal and mutated sequence variants, associated with disease, genetic linkage analysis of biallelic markers, and quantification of gene expression in a tissue sample.
  • a kit for detecting a target nucleic acid sequence in a sample comprising a) a padlock probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence; and b) a means for connecting the ends to each other after hybridization to the target sequence.
  • the kit according to the invention is characterized in c) a cleavable or dissociable detectable function; and, optionally, d) a cleaving agent.
  • the padlock probe has two linear probe ends, one of the probe ends containing a detectable function which is cleavable or dissociable.
  • At least one of the two free nucleic acid end parts of the padlock probe is branched, e.g. with up to ten branches or even more, and each of the branches or arms is provided with a different detectable function.
  • the present invention provides for use of the above kit for distinction between sequence-specific variants of nucleic acids, such as allele-specific variants.
  • a padlock probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence, and at least one cleavable or dissociable function on one of the end parts of the probe.
  • a padlock probe having two free nucleic acid end parts, where at least one of the two end parts is branched.
  • Fig. 1 shows a monospecific cleavable detectable probe
  • Fig. 2 shows a monospecific dissociable detectable probe
  • Fig. 3 shows a bispecific cleavable detectable probe having differentially labelled sequence variant-specific and cleavable probe branches
  • Fig. 4 shows a bispecific dissociable detectable probe having differentially labelled sequence variant-specific secondary padlock probes, attached to sequence variant- specific branches;
  • Fig. 5 shows a variant of a monospecific dissociable detectable probe where the detectable function is provided on the target-sequence specific probe
  • Fig. 6 shows the DNA sequences of a cleavable padlock probe and a complementary target sequence
  • Fig. 7 shows the two DNA sequences in Fig. 6 together with the DNA sequence of a padlock probe complementary to the back-piece of the cleavable padlock probe.
  • cleavable links and cleaving agents include disulphides, cleavable by reducing agents such as dithiothreitol, deoxyuridine residues, cleavable by uracil DNA glycosylase; peptide residues cleavable by peptidases and nucleotide sequences susceptible to cleavage by endonucleases.
  • the two ends hybridize in juxtapositon on a target sequence, then they can become joined by an act of template-dependent ligation and thereby catenated to the target sequence as described in more detail in the above- mentioned WO 95/22623 (the disclosure of which is incorporated herein by reference) .
  • the cleavable linker is broken and the support is washed vigorously. Any remaining detectable group indicates that this has become joined to the support via the other probe arm.
  • the probe thus functions as a logic "OR" gate, giving a positive answer as long as one or both of the links to the support are intact.
  • the probes are constructed such that a secondary, detectable padlock probe D is allowed to circularize around the back-piece of a specific target detection padlock probe, bound to the support. If and only if this specific probe interacts with its target and is cyclized, then the detectable padlock probe will remain bound to the support after denaturing washes.
  • the detection probes can be designed as shown in Figs. 3 and 4 to include a single 3 ' end and at the other end branching into two allele-specific 5' ends (or the other way around) .
  • the sequence variant-specific probe segments can be designed to hybridize with lesser stability and they each have distinct cleavable, C, C", or dissociable detectable, C , D' , C", D” , functions. In this manner all target sequences can give rise to a signal but only from that sequence variant-specific probe that hybridizes and ligates the best.
  • Fig. 5 shows an alternative embodiment of monospecific dissociable detectable probe to that shown in Fig. 2. While in Fig. 2, the target-sequence specific probe is immobilized and linked to the non-specific signal- generating padlock probe, D, the embodiment shown in Fig. 5 has the non-specific probe, E, immobilized and the detectable probe F is also target-sequence specific.
  • the methods of the invention can be be performed on immobilized target sequences, such as metaphase chromosomes. Following the ligation and washes at or above stringency, the probes are opened and the reaction washed resulting in the disappearance of free ends, but ends connected via hybridization retain their binding with the target sequence.
  • target sequences such as metaphase chromosomes.
  • probes according to the invention avoid both of these limitations.
  • one important difficulty of using complex samples as templates remain, viz. it is important to arrange the assay so that a DNA sample (preferably sheared or otherwise reduced in average size) is brought in close contact with all positions in a probe array. For this reason, one- dimensional probe arrays are envisioned for this purpose.
  • a padlock probe of a defined specificity (below to Factor V) is synthesized with a few thymine (T) bases replaced by uracil (U) bases and is covalently immobilized to a surface or immobilized via biotin to a streptavidin-coated surface. Beyond the coupling site to the surface the padlock probe has a detectable tag, e.g. a fluorophore, and the uracil- containing part.
  • the padlock probe is hybridized and ligated to its template and treated with the enzyme uracil DNA glycosylase (UDG) .
  • UDG uracil DNA glycosylase
  • TJDG cleaves off the uracil bases from the padlock probe to leave the phosphodiester bond. This abasic binding is unstable and is easily broken by heat, basic pH or Exonuclease III. If ligation has taken place, the tag signal will remain after wash, but if no ligation has taken place, the signal tag may be washed away since that part of the padlock probe is no longer connected to the rest of the probe and is thereby not attached to the surface.
  • padlock probe A has specificity to a template (below Factor V) and also exhibits a back-piece sequence which is complementary to the other probe B.
  • Padlock probe B is tagged, e.g. with a fluorophore.
  • padlock probe A can be circularized in the ligation to its template consisting of a complementary oligonucleotide;
  • padlock probe B can be circularized to padlock probe A; and
  • padlock probes A and B can be circularized in the ligation to template.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PCT/SE1997/000737 1996-04-30 1997-04-30 Improved probing of specific nucleic acids Ceased WO1997041254A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP97921072A EP0951565B1 (en) 1996-04-30 1997-04-30 Improved probing of specific nucleic acids
DE69719557T DE69719557T2 (de) 1996-04-30 1997-04-30 Verbesserte erkennung von spezifischen nukleinsäuren
CA002252817A CA2252817C (en) 1996-04-30 1997-04-30 Improved probing of specific nucleic acids
JP9538820A JP2000508920A (ja) 1996-04-30 1997-04-30 特異的核酸の改善された探索
AT97921072T ATE233826T1 (de) 1996-04-30 1997-04-30 Verbesserte erkennung von spezifischen nukleinsäuren
US10/029,913 US7351528B2 (en) 1996-04-30 2001-12-31 Probing of specific nucleic acids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601676-1 1996-04-30
SE9601676A SE9601676D0 (sv) 1996-04-30 1996-04-30 Improved probing of specific mucleic acids

Publications (1)

Publication Number Publication Date
WO1997041254A1 true WO1997041254A1 (en) 1997-11-06

Family

ID=20402429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1997/000737 Ceased WO1997041254A1 (en) 1996-04-30 1997-04-30 Improved probing of specific nucleic acids

Country Status (8)

Country Link
US (2) US20010007742A1 (https=)
EP (1) EP0951565B1 (https=)
JP (1) JP2000508920A (https=)
AT (1) ATE233826T1 (https=)
CA (1) CA2252817C (https=)
DE (1) DE69719557T2 (https=)
SE (1) SE9601676D0 (https=)
WO (1) WO1997041254A1 (https=)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005024053A1 (en) * 2003-09-04 2005-03-17 Human Genetic Signatures Pty Ltd Nucleic acid detection assay
WO2009121021A1 (en) * 2008-03-28 2009-10-01 Life Technologies Corporation Degradable arrays for preventing reuse
US7615625B2 (en) 1992-08-04 2009-11-10 Replicon, Inc. In vitro amplification of nucleic acid molecules via circular replicons
US7799525B2 (en) 2003-06-17 2010-09-21 Human Genetic Signatures Pty Ltd. Methods for genome amplification
US7803580B2 (en) 2004-09-10 2010-09-28 Human Genetic Signatures Pty. Ltd. Amplification blocker comprising intercalating nucleic acids (INA) containing intercalating pseudonucleotides (IPN)
US7833942B2 (en) 2004-12-03 2010-11-16 Human Genetic Signatures Pty. Ltd. Methods for simplifying microbial nucleic acids by chemical modification of cytosines
US8168777B2 (en) 2004-04-29 2012-05-01 Human Genetic Signatures Pty. Ltd. Bisulphite reagent treatment of nucleic acid
US8343738B2 (en) 2005-09-14 2013-01-01 Human Genetic Signatures Pty. Ltd. Assay for screening for potential cervical cancer
US8431347B2 (en) 2005-05-26 2013-04-30 Human Genetic Signatures Pty Ltd Isothermal strand displacement amplification using primers containing a non-regular base
US8685675B2 (en) 2007-11-27 2014-04-01 Human Genetic Signatures Pty. Ltd. Enzymes for amplification and copying bisulphite modified nucleic acids
US9127312B2 (en) 2011-02-09 2015-09-08 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
US9732375B2 (en) 2011-09-07 2017-08-15 Human Genetic Signatures Pty. Ltd. Molecular detection assay using direct treatment with a bisulphite reagent

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261808B1 (en) * 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
CA2505687A1 (en) * 2002-11-19 2004-06-03 Applera Corporation Polynucleotide sequence detection assays and analysis
US20050053957A1 (en) * 2002-11-19 2005-03-10 Applera Corporation Polynucleotide sequence detection assays
US7618780B2 (en) * 2004-05-20 2009-11-17 Trillion Genomics Limited Use of mass labelled probes to detect target nucleic acids using mass spectrometry
EP1879377A3 (en) * 2006-07-13 2010-06-16 Panasonic Corporation Portable Device
US8470542B2 (en) * 2008-12-01 2013-06-25 Laboratory Corporation Of America Holdings Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
SG172983A1 (en) 2009-01-15 2011-08-29 Lab Corp America Holdings Methods of determining patient response by measurement of her-3
SG172984A1 (en) * 2009-01-15 2011-08-29 Lab Corp America Holdings Methods of determining patient response by measurement of her-2 expression
US12129514B2 (en) 2009-04-30 2024-10-29 Molecular Loop Biosolutions, Llc Methods and compositions for evaluating genetic markers
EP2425240A4 (en) 2009-04-30 2012-12-12 Good Start Genetics Inc METHOD AND COMPOSITION FOR EVALUATING GENETIC MARKERS
JP2013511991A (ja) * 2009-11-25 2013-04-11 クアンタライフ, インコーポレイテッド 遺伝子材料を検出する方法および組成物
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
EP2675916B1 (en) 2011-02-15 2016-08-24 Leica Biosystems Newcastle Limited METHOD FOR LOCALIZED IN SITU DETECTION OF mRNA
US9556473B2 (en) 2011-02-15 2017-01-31 Leica Biosystems Newcastle Ltd Methods for identifying nucleic acid sequences
US8759036B2 (en) 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
US8932819B2 (en) 2011-07-06 2015-01-13 Affymetrix, Inc. Assays for affinity profiling of nucleic acid binding proteins
CA2852665A1 (en) 2011-10-17 2013-04-25 Good Start Genetics, Inc. Analysis methods
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US8812422B2 (en) 2012-04-09 2014-08-19 Good Start Genetics, Inc. Variant database
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
CA2904181A1 (en) 2013-03-13 2014-10-09 Anahit Aghvanyan Sandwich immunoassay comprising anchoring reagent
US10114015B2 (en) 2013-03-13 2018-10-30 Meso Scale Technologies, Llc. Assay methods
WO2014152421A1 (en) 2013-03-14 2014-09-25 Good Start Genetics, Inc. Methods for analyzing nucleic acids
KR102134168B1 (ko) 2013-03-15 2020-07-15 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 중금속이 없는 씨피브이씨 조성물
US8847799B1 (en) 2013-06-03 2014-09-30 Good Start Genetics, Inc. Methods and systems for storing sequence read data
WO2015013681A1 (en) 2013-07-25 2015-01-29 Bio-Rad Laboratories, Inc. Genetic assays
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
US11041203B2 (en) 2013-10-18 2021-06-22 Molecular Loop Biosolutions, Inc. Methods for assessing a genomic region of a subject
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
WO2015175856A1 (en) 2014-05-15 2015-11-19 Meso Scale Technologies, Llc. Improved assay methods
KR102535489B1 (ko) 2014-06-13 2023-05-22 큐-리네아 에이비 미생물 검출 방법 및 특성 규명 방법
US20160048608A1 (en) 2014-08-15 2016-02-18 Good Start Genetics, Inc. Systems and methods for genetic analysis
US11408024B2 (en) 2014-09-10 2022-08-09 Molecular Loop Biosciences, Inc. Methods for selectively suppressing non-target sequences
US10429399B2 (en) 2014-09-24 2019-10-01 Good Start Genetics, Inc. Process control for increased robustness of genetic assays
EP3209798B1 (en) 2014-10-23 2022-07-27 Ricardo Mancebo Reagents and methods for isothermal chain reaction
EP4095261B1 (en) 2015-01-06 2025-05-28 Molecular Loop Biosciences, Inc. Screening for structural variants
GB201507026D0 (en) 2015-04-24 2015-06-10 Linea Ab Q Medical sample transportation container
ES2745556T3 (es) 2015-07-29 2020-03-02 Progenity Inc Acidos nucleicos y métodos para detectar anomalías cromosómicas
CA3005101A1 (en) 2015-11-16 2017-05-26 Progenity, Inc. Nucleic acids and methods for detecting methylation status
GB2554767A (en) 2016-04-21 2018-04-11 Q Linea Ab Detecting and characterising a microorganism
DK3548652T3 (da) 2016-12-01 2024-07-08 Nautilus Subsidiary Inc Fremgangsmåder til proteinanalyse
US11661624B2 (en) 2017-03-30 2023-05-30 Pioneer Hi-Bred International, Inc. Methods of identifying and characterizing gene editing variations in nucleic acids
KR20250152680A (ko) 2017-12-29 2025-10-23 노틸러스 서브시디어리, 인크. 단백질 식별을 위한 디코딩 접근법
WO2019195346A1 (en) 2018-04-02 2019-10-10 Progenity, Inc. Methods, systems, and compositions for counting nucleic acid molecules
AU2020232954B2 (en) 2019-03-01 2026-01-15 Meso Scale Technologies, Llc. Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same
EP3947718A4 (en) 2019-04-02 2022-12-21 Enumera Molecular, Inc. METHODS, SYSTEMS AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES
JP7727628B2 (ja) 2019-12-03 2025-08-21 アラマー バイオサイエンシーズ, インク. 核酸結合免疫サンドイッチアッセイ(nulisa)
GB202004469D0 (en) 2020-03-27 2020-05-13 Olink Proteomics Ab Controls for proximity detection assays
AU2021288692A1 (en) 2020-06-11 2023-02-02 Nautilus Subsidiary, Inc. Methods and systems for computational decoding of biological, chemical, and physical entities
CN116438454A (zh) 2020-09-21 2023-07-14 普罗根尼蒂公司 用于分离细胞游离dna的组合物和方法
EP4281774B1 (en) 2021-01-20 2025-11-26 Nautilus Subsidiary, Inc. Biomolecule quantitation
EP4281775B1 (en) 2021-01-21 2026-04-29 Nautilus Subsidiary, Inc. Systems and methods for biomolecule preparation
IL305336B2 (en) 2021-03-11 2025-09-01 Nautilus Subsidiary Inc Systems and methods for preserving biomolecules
CA3227872A1 (en) 2021-09-09 2023-03-16 James Henry JOLY Characterization and localization of protein modifications
CA3227592A1 (en) 2021-09-22 2023-03-30 Gregory KAPP Methods and systems for determining polypeptide interactions
US20230149883A1 (en) 2021-11-03 2023-05-18 Nautilus Biotechnology, Inc. Systems and methods for surface structuring
US12092578B2 (en) 2022-03-29 2024-09-17 Nautilus Subsidiary, Inc. Integrated arrays for single-analyte processes
WO2023212490A1 (en) 2022-04-25 2023-11-02 Nautilus Subsidiary, Inc. Systems and methods for assessing and improving the quality of multiplex molecular assays
EP4544077A1 (en) 2022-06-21 2025-04-30 Nautilus Subsidiary, Inc. Method for detecting analytes at sites of optically non-resolvable distances
WO2024059655A1 (en) 2022-09-15 2024-03-21 Nautilus Subsidiary, Inc. Characterizing accessibility of macromolecule structures
WO2024073599A1 (en) 2022-09-29 2024-04-04 Nautilus Subsidiary, Inc. Preparation of array surfaces for single-analyte processes
WO2024124073A1 (en) 2022-12-09 2024-06-13 Nautilus Subsidiary, Inc. A method comprising performing on a single-analyte array at least 50 cycles of a process
US20240201182A1 (en) 2022-12-15 2024-06-20 Nautilus Subsidiary, Inc. Inhibition of photon phenomena on single molecule arrays
EP4689173A1 (en) 2023-03-24 2026-02-11 Nautilus Subsidiary, Inc. Improved transfer of nanoparticles to array surfaces
US20240394902A1 (en) 2023-05-24 2024-11-28 Nautilus Subsidiary, Inc. Systems and methods for machine vision
US20250066841A1 (en) 2023-08-24 2025-02-27 Nautilus Subsidiary, Inc. Compositions and methods for detecting binding interactions under equilibrium or non-equilibrium conditions
US20250189519A1 (en) 2023-12-11 2025-06-12 Nautilus Subsidiary, Inc. Methods and compositions of particle-based arrays
WO2025137166A1 (en) 2023-12-20 2025-06-26 Nautilus Subsidiary, Inc. Fluidic devices for single-analyte assays
US20250298016A1 (en) 2024-03-22 2025-09-25 Nautilus Subsidiary, Inc. Plasmonic particle systems for single-analyte assays
WO2025212338A1 (en) 2024-04-01 2025-10-09 Nautilus Subsidiary, Inc. Nanostructures for modulation of analyte conformation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022623A1 (en) * 1994-02-16 1995-08-24 Ulf Landegren Circularizing nucleic acid probe able to interlock with a target sequence through catenation
WO1996003525A1 (en) * 1994-07-25 1996-02-08 Raggio-Italgene S.P.A. Method and reagents for the detection of target nucleic acid sequences

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5427930A (en) * 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
US5643724A (en) * 1994-06-06 1997-07-01 Roche Molecular Systems, Inc. Methods and reagents for Glycophorin A typing
JP3790797B2 (ja) 1995-07-11 2006-06-28 フォーファス グリコシラーゼによる候補座位のヌクレオチド配列の検出

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022623A1 (en) * 1994-02-16 1995-08-24 Ulf Landegren Circularizing nucleic acid probe able to interlock with a target sequence through catenation
WO1996003525A1 (en) * 1994-07-25 1996-02-08 Raggio-Italgene S.P.A. Method and reagents for the detection of target nucleic acid sequences

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615625B2 (en) 1992-08-04 2009-11-10 Replicon, Inc. In vitro amplification of nucleic acid molecules via circular replicons
US7799525B2 (en) 2003-06-17 2010-09-21 Human Genetic Signatures Pty Ltd. Methods for genome amplification
US7846693B2 (en) 2003-09-04 2010-12-07 Human Genetic Signatures Pty. Ltd. Nucleic acid detection assay
WO2005024053A1 (en) * 2003-09-04 2005-03-17 Human Genetic Signatures Pty Ltd Nucleic acid detection assay
US8168777B2 (en) 2004-04-29 2012-05-01 Human Genetic Signatures Pty. Ltd. Bisulphite reagent treatment of nucleic acid
US7803580B2 (en) 2004-09-10 2010-09-28 Human Genetic Signatures Pty. Ltd. Amplification blocker comprising intercalating nucleic acids (INA) containing intercalating pseudonucleotides (IPN)
US8598088B2 (en) 2004-12-03 2013-12-03 Human Genetic Signatures Pty. Ltd. Methods for simplifying microbial nucleic acids by chemical modification of cytosines
US7833942B2 (en) 2004-12-03 2010-11-16 Human Genetic Signatures Pty. Ltd. Methods for simplifying microbial nucleic acids by chemical modification of cytosines
US8431347B2 (en) 2005-05-26 2013-04-30 Human Genetic Signatures Pty Ltd Isothermal strand displacement amplification using primers containing a non-regular base
US8343738B2 (en) 2005-09-14 2013-01-01 Human Genetic Signatures Pty. Ltd. Assay for screening for potential cervical cancer
US8685675B2 (en) 2007-11-27 2014-04-01 Human Genetic Signatures Pty. Ltd. Enzymes for amplification and copying bisulphite modified nucleic acids
WO2009121021A1 (en) * 2008-03-28 2009-10-01 Life Technologies Corporation Degradable arrays for preventing reuse
US9127312B2 (en) 2011-02-09 2015-09-08 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
US10167509B2 (en) 2011-02-09 2019-01-01 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
US11499181B2 (en) 2011-02-09 2022-11-15 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
US9732375B2 (en) 2011-09-07 2017-08-15 Human Genetic Signatures Pty. Ltd. Molecular detection assay using direct treatment with a bisulphite reagent

Also Published As

Publication number Publication date
DE69719557T2 (de) 2004-02-26
SE9601676D0 (sv) 1996-04-30
CA2252817A1 (en) 1997-11-06
EP0951565A1 (en) 1999-10-27
US20020102592A1 (en) 2002-08-01
DE69719557D1 (de) 2003-04-10
ATE233826T1 (de) 2003-03-15
EP0951565B1 (en) 2003-03-05
CA2252817C (en) 2009-07-07
US7351528B2 (en) 2008-04-01
US20010007742A1 (en) 2001-07-12
JP2000508920A (ja) 2000-07-18

Similar Documents

Publication Publication Date Title
EP0951565B1 (en) Improved probing of specific nucleic acids
US7914989B2 (en) Capture moieties for nucleic acids and uses thereof
CN1863927B (zh) 核酸检测分析
US5770365A (en) Nucleic acid capture moieties
EP1090138A1 (en) Nucleotide detection method
EP0745140A1 (en) Circularizing nucleic acid probe able to interlock with a target sequence through catenation
CA2406096A1 (en) Degradable nucleic acid probes and nucleic acid detection methods
WO2002024955A2 (en) Detection of unlabeled hybridized dna and rna using restriction enzyme digestion
AU772995B2 (en) Methods of synthesizing polynucleotides by ligation of multiple oligomers
US6020132A (en) Method of analysis using signal amplification
EP0857791B1 (en) Method of analysis using signal amplification
EP1135525A2 (en) Methods and compositions for detection of nucleic acid sequences and signal amplification
EP2561098B1 (en) Tethered enzyme mediated nucleic acid detection
AU2004270756B2 (en) Nucleic acid detection assay
AU1523799A (en) Methods and compositions for detection of specific nucleotide sequences
AU2011242404A1 (en) Tethered enzyme mediated nucleic acid detection
AU2001259096A1 (en) Degradable nucleic acid probes and nucleic acid detection methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2252817

Country of ref document: CA

Ref country code: CA

Ref document number: 2252817

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997921072

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09171935

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997921072

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1997921072

Country of ref document: EP